Compound comparisons

One is a small-molecule enzyme inhibitor, the other a mitochondrial-derived peptide. They are not the same class of compound at all.

Both are marketed under the anti-ageing heading. One is a coenzyme central to cell metabolism with a broad literature; the other is a short…

LR3 is not a strength or a grade. It is a structural modification that changes how the molecule interacts with its binding proteins.

PT-141 is derived from Melanotan II. What changed between them is receptor selectivity, and that is the whole distinction.

All three act at the same receptor. They differ in fragment length, stability and how much published human data stands behind each.

Both appear in gastrointestinal research, which is why they get compared. The pathways each is studied for are different.

Melanotan I is selective for one melanocortin receptor. Melanotan II is not – and that non-selectivity is the reason the two are studied differently.

Both are studied in mitochondrial biology, but one is a signalling peptide encoded by mitochondrial DNA and the other targets the inner mitochondrial membrane…

Single, dual and triple receptor agonists differ by which incretin receptors they activate. A research comparison of mechanism, study stage and laboratory handling.

Two of these are GHRH analogs and one is a ghrelin-receptor secretagogue. Which receptor each engages explains why they are studied together rather than…